8.36
3.34%
0.27
Kalvista Pharmaceuticals Inc (KALV) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 | 2024-01-31 | 2023-10-31 | 2023-07-31 | 2023-04-30 | 2023-01-31 |
기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
Revenues |
-
|
- | - | - | - |
Operating Expenses
|
11.45%
33.15
|
29.75 | 29.09 | 31.73 | 26.95 |
Operating Income/Loss |
11.45%
-33.15
|
-29.75 | -29.09 | -31.73 | -26.95 |
Nonoperating Income/Loss |
96.71%
4.123
|
2.096 | 3.776 | 5.423 | 5.642 |
Income/Loss From Continuing Operations Before Tax |
4.98%
-29.03
|
-27.65 | -25.32 | -26.30 | -21.30 |
Income/Loss From Continuing Operations After Tax |
4.98%
-29.03
|
-27.65 | -25.32 | -26.30 | -21.30 |
Net Income/Loss
|
4.98%
-29.03
|
-27.65 | -25.32 | -26.30 | -21.30 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
0.46%
34.72
|
34.57 | 34.41 | 2.0805 | 28.28 |
Diluted Average Shares |
0.46%
34.72
|
34.57 | 34.41 | 2.0805 | 28.28 |
Basic Earnings Per Share |
5.00%
-0.84
|
-0.80 | -0.74 | -0.75 | -0.75 |
Diluted Earnings Per Share |
5.00%
-0.84
|
-0.80 | -0.74 | -0.75 | -0.75 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
자본화:
|
볼륨(24시간):